Tigist W. Leulseged
Stellenbosch University, South Africa
Posters & Accepted Abstracts: Altern Integr Med
Background: Diabetes is a chronic, progressive disease characterized by elevated levels of blood glucose.
Poorly managed diabetes leads to serious complications and early death. The prevalence of diabetes has been
increasing over the past few decades. Ethiopia is one of African countries with the highest number of people
living with diabetes. Studies conducted in Ethiopia and other countries mainly focused on level of glycaemic
control at one point in time. Studies targeting the time that a patient stayed in a poor glycaemic level are
lacking.
Objectives: To estimate time to first optimal glycaemic control and to identify prognostic factors among type
2 diabetes mellitus (T2DM) patients in public teaching hospitals in Addis Ababa, Ethiopia.
Methods: A hospital based retrospective chart review study was conducted from April to July 2018 at diabetes
clinic of Addis Ababaâ??s public teaching among randomly selected sample of 685 charts of T2DM patients who
were on follow up from January 1 2013 to June 30 2017. Data was collected using pretested data abstraction
tool. Data was checked, coded and entered to Epi-Info V.7.2.1.0 and exported to SPSS V.23.0 and STATA
V.14.1 for analysis. Descriptive statistics is presented with frequency tables, Kaplan Meier plots and median
survival times. Association was done using Log-rank test and Cox proportional hazard survival model, where
hazard ratio, P-value and 95% CI for hazard ratio were used for testing significance and interpretation of
results.
Results: Median time to first optimal glycaemic control among the study population was 9.5 months. The
major factors that affect it are age group (HR=0.635, 95% CI: 0.486-0.831 for 50-59 years, HR=0.558, 95%
CI: 0.403-0.771for 60-69 years and HR=0.495, 95% CI: 0.310-0.790 for >=70 years), diabetes neuropathy
(HR=0.502, 95% CI: 0.375-0.672), more than one complication (HR=0.381, 95% CI: 0.177-0.816), hypertension
(HR=0.611, 95% CI: 0.486-0.769), dyslipidemia (HR=0.609, 95% CI: 0.450-0.824), cardiovascular disease
(HR=0.670, 95% CI: 0.458-0.979) and hospital patient treated at (HR=1.273, 95% CI: 1.052-1.541).
Conclusions: Median time to first optimal glycaemic control among T2DM patients is longer than expected
which might imply that patients are being exposed to more risk of complication and death.
E-mail: birtesh@gmail.com
Alternative & Integrative Medicine received 476 citations as per Google Scholar report